Literature DB >> 29862496

Clinical oversight and the avoidance of repeat induced abortion.

Erica L Jacovetty1, Camille A Clare1, Mary-Beatrice Squire1, Keshar P Kubal2, Sherry Liou3, Mario A Inchiosa2,4.   

Abstract

OBJECTIVE: To evaluate the impact of patient counseling, demographics, and contraceptive methods on repeat induced abortion in women attending family planning clinics.
METHODS: A retrospective chart review of repeat induced abortions was performed. The analysis included patients with an initial induced abortion obtained between January 1, 2001, and March 31, 2014, at New York City Health + Hospitals/Metropolitan. The duration of involvement in the family planning program, the use of contraceptive interventions, and 18 patient factors were analyzed for their correlation with the incidence of repeat induced abortions per year of follow-up.
RESULTS: A decreased rate of repeat induced abortions was associated with a longer duration of clinical oversight (r2 =0.449, P<0.001), a higher contraceptive efficacy score (r=0.280, P=0.025), and a larger number of clinic visits for contraception (r=0.333, P=0.007).
CONCLUSION: A continuum of contact with all of the services of a family planning clinic demonstrated a strong efficacy to limit repeat induced abortions. By determining the patient characteristics that most influence repeat induced abortion rates, providers can best choose the most efficacious method of contraception available.
© 2018 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Clinical oversight; Contraceptive choice; Counseling; Family planning resources; Patient characteristics; Repeat induced abortion

Mesh:

Substances:

Year:  2018        PMID: 29862496     DOI: 10.1002/ijgo.12543

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Factors related to the voluntary interruption of pregnancy in Spain.

Authors:  Sofía García Senso; Marta Cara RODRíGUEZ; MARíA Ángeles RODRíGUEZ-Arenas
Journal:  J Prev Med Hyg       Date:  2022-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.